CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-04 | Shukla Sanjay President and CEO | Sale | −3,745 | $0.98 | $4K | 153,553 |
| 2026-02-04 | Broadfoot Jill Marie Chief Financial Officer | Sale | −1,558 | $0.98 | $2K | 37,296 |
| 2026-02-04 | DENYES NANCY General Counsel | Sale | −1,118 | $0.98 | $1K | 33,124 |
| 2025-02-04 | Broadfoot Jill Marie Chief Financial Officer | Sale | −1,254 | $3.78 | $5K | 31,763 |
| 2025-02-04 | DENYES NANCY General Counsel | Sale | −899 | $3.78 | $3K | 26,555 |
| 2024-02-06 | Broadfoot Jill Marie Chief Financial Officer | Sale | −1,590 | $1.69 | $3K | 20,821 |
| 2023-02-06 | Broadfoot Jill Marie Chief Financial Officer | Sale | −1,566 | $2.36 | $4K | 15,460 |
| 2021-05-21 | CLARKE JOHN K Director | Sale | −2,500 | $4.34 | $11K | 108,083 |
| 2021-02-09 | Broadfoot Jill Marie Chief Financial Officer | Sale | −390 | $7.66 | $3K | 9,833 |
| 2021-02-09 | Shukla Sanjay President and CEO | Sale | −778 | $7.66 | $6K | 8,298 |
| 2020-09-02 | CLARKE JOHN K Director | Sale | −7,260 | $4.01 | $29K | 110,583 |
| 2020-08-28 | CLARKE JOHN K Director | Sale | −100 | $4.00 | $400 | 117,843 |
| 2020-08-27 | CLARKE JOHN K Director | Sale | −5,440 | $4.09 | $22K | 117,943 |
| 2020-08-26 | CLARKE JOHN K Director | Sale | −2,200 | $4.30 | $9K | 123,383 |
| 2020-05-20 | DENYES NANCY General Counsel | Sale | −322 | $3.62 | $1K | 2,735 |
| 2020-05-20 | SCHIMMEL PAUL Director | Sale | −8,447 | $3.64 | $31K | 429,143 |
| 2020-02-07 | Shukla Sanjay President and CEO | Sale | −745 | $4.03 | $3K | 1,291 |
| 2020-02-07 | Broadfoot Jill Marie Chief Financial Officer | Sale | −375 | $4.03 | $2K | 7,125 |
| 2019-05-17 | Krueger Nancy General Counsel | Sale | −4,651 | $0.45 | $2K | 25,348 |
| 2018-05-16 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −2,733,231 | $0.81 | $2.2M | 0 |
Page 1 of 2 · 28 trades